What's Driving Day One's Recent Surge? The Servier Acquisition Explained.

Related Articles

What Does Servier's $2.5 Billion Acquisition Mean for Day One Biopharmaceuticals

3 months ago

What Just Happened with Day One Biopharmaceuticals and Servier

3 months ago

Why Did Servier Pay a 68% Premium for Day One Biopharmaceuticals

3 months ago

What's Driving AltC Acquisition's Recent Surge

2 months ago

Category

You may also like

Stock News•1 week ago

The Surprising Reversal That Drove Acadia Pharma Closer To A Breakout

Acadia Pharma rose Friday after European regulators unexpectedly recommended approval of its Rett syndrome drug, Daybu.

ACAD

Share

Stock News•1 months ago

Edgewise Therapeutics Stock Hits Record High on $2.65B Servier Deal

Edgewise Therapeutics shares surged 18% to a record high after the company announced a $2.65 billion neuromuscular business divestiture to Servier. The deal allows Edgewise to sharpen its strategic fo...

EWTX

Share

Stock News•1 months ago

SELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move?

SELLAS Life Sciences (SLS) shares rose Wednesday as investors reacted to a pipeline update regarding its acute myeloid leukemia program. The company provided a clarified timeline for its upcoming pivo...

SLS

Share

Stock News•2 months ago

There's a Revolution in Cancer. But Can Big Pharma Afford It?

Revolution Medicines shares surged following positive developments for its pancreatic-cancer drug candidate. Despite market speculation, a near-term acquisition appears unlikely, suggesting investors ...

RVMD

Share